Raymond James & Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $11.6M | Buy |
158,852
+4,325
| +3% | +$316K | 0.01% | 1134 |
|
2024
Q2 | $10.6M | Sell |
154,527
-1,519
| -1% | -$104K | 0.01% | 1131 |
|
2024
Q1 | $10.8M | Buy |
156,046
+17,191
| +12% | +$1.19M | 0.01% | 1108 |
|
2023
Q4 | $9.94M | Sell |
138,855
-10,590
| -7% | -$758K | 0.01% | 1110 |
|
2023
Q3 | $7.78M | Buy |
149,445
+5,716
| +4% | +$298K | 0.01% | 1193 |
|
2023
Q2 | $9.1M | Buy |
143,729
+633
| +0.4% | +$40.1K | 0.01% | 1108 |
|
2023
Q1 | $7.75M | Sell |
143,096
-1,802
| -1% | -$97.6K | 0.01% | 1185 |
|
2022
Q4 | $7.67M | Sell |
144,898
-19,234
| -12% | -$1.02M | 0.01% | 1157 |
|
2022
Q3 | $7.64M | Buy |
164,132
+14,532
| +10% | +$676K | 0.01% | 1114 |
|
2022
Q2 | $8.54M | Buy |
149,600
+624
| +0.4% | +$35.6K | 0.01% | 1061 |
|
2022
Q1 | $9.12M | Buy |
148,976
+9,233
| +7% | +$565K | 0.01% | 1122 |
|
2021
Q4 | $7.31M | Buy |
139,743
+5,761
| +4% | +$302K | 0.01% | 1289 |
|
2021
Q3 | $5M | Buy |
133,982
+20,434
| +18% | +$762K | ﹤0.01% | 1496 |
|
2021
Q2 | $4.64M | Buy |
113,548
+30,319
| +36% | +$1.24M | ﹤0.01% | 1539 |
|
2021
Q1 | $2.82M | Buy |
83,229
+880
| +1% | +$29.9K | ﹤0.01% | 1789 |
|
2020
Q4 | $2.62M | Sell |
82,349
-73,165
| -47% | -$2.33M | ﹤0.01% | 1731 |
|
2020
Q3 | $3.99M | Sell |
155,514
-9,548
| -6% | -$245K | 0.01% | 1355 |
|
2020
Q2 | $4.24M | Buy |
165,062
+32,209
| +24% | +$827K | 0.01% | 1290 |
|
2020
Q1 | $2.04M | Sell |
132,853
-2,347
| -2% | -$36.1K | ﹤0.01% | 1557 |
|
2019
Q4 | $4.64M | Buy |
135,200
+44,655
| +49% | +$1.53M | 0.01% | 1303 |
|
2019
Q3 | $676K | Buy |
90,545
+6,095
| +7% | +$45.5K | ﹤0.01% | 2444 |
|
2019
Q2 | $1.1M | Buy |
84,450
+15,800
| +23% | +$205K | ﹤0.01% | 2157 |
|
2019
Q1 | $836K | Buy |
68,650
+35,476
| +107% | +$432K | ﹤0.01% | 2309 |
|
2018
Q4 | $378K | Sell |
33,174
-37,626
| -53% | -$429K | ﹤0.01% | 2728 |
|
2018
Q3 | $1.54M | Buy |
70,800
+6,650
| +10% | +$144K | ﹤0.01% | 1970 |
|
2018
Q2 | $1.13M | Buy |
64,150
+15,918
| +33% | +$281K | ﹤0.01% | 2111 |
|
2018
Q1 | $1.02M | Buy |
48,232
+31,882
| +195% | +$671K | ﹤0.01% | 2114 |
|
2017
Q4 | $237K | Buy |
+16,350
| New | +$237K | ﹤0.01% | 2945 |
|